FUSED POLYCYCLIC HETEROCYCLE DERIVATIVES
    4.
    发明公开
    FUSED POLYCYCLIC HETEROCYCLE DERIVATIVES 失效
    VERKNÜPFTE聚合物杂环化合物VERBINDUNGEN

    公开(公告)号:EP0831094A1

    公开(公告)日:1998-03-25

    申请号:EP96920027.8

    申请日:1996-05-31

    申请人: Eisai Co., Ltd.

    摘要: Novel fused polycyclic heterocycle derivatives having excellent antitumor effects and a process for producing the same.
    A compound represented by the following general formula (I) or pharmacologically acceptable salts thereof:
    wherein the ring A represents an optionally substituted monocyclic aromatic ring or a dicyclic fused ring in which at least one of the rings is an aromatic ring; the ring B represents pyrrole, 4H-1,4-oxazine, 4H-1,4-thiazine or 4(1H)-pyridone; the ring C represents an optionally substituted, monocyclic or dicyclic fused aromatic ring; and Y represents a group represented by the formula -e-f (wherein e represents a lower alkylene; and f represents amidino, guanidino or amino optionally substituted by optionally hydroxylated or optionally lower-alkylaminated lower alkyl;
       provided that the cases where the rings A and B are both optionally substituted monocyclic aromatic rings are excluded.
    Which has an excellent antitumor activity.

    摘要翻译: 具有优异抗肿瘤效果的新型稠合多环杂环衍生物及其制备方法。 由以下通式(I)表示的化合物或其药理学上可接受的盐:其中环A表示任选取代的单环芳环或二环稠合环,其中至少一个环为芳环; 环B表示吡咯,4H-1,4-恶嗪,4H-1,4-噻嗪或4(1H) - 吡啶酮; 环C表示任选取代的单环或二环稠合芳环; Y表示由式-ef表示的基团(其中e表示低级亚烷基; f表示任选被羟基化或任选低级烷基化的低级烷基取代的脒基,胍基或氨基);条件是环A和B 均为任选取代的单环芳环,其具有优异的抗肿瘤活性。